文献速递心境障碍

抗抑郁安慰剂期望与心境之间的动态反馈

Dynamic Feedback Between Antidepressant Placebo Expectancies and Mood.
PubMed 文献 · JAMA Psychiatry · 2023-01-01

本研究在60例未服药的抑郁症患者中,用功能磁共振任务操纵抗抑郁安慰剂期望,结合强化学习框架分析期望与心境的逐试次演变。贝叶斯强化学习模型显示,安慰剂期望由整合感觉证据与逐试次心境的复合学习信号更新;学习到的期望编码于突显网络,且与抑郁严重程度正相关。

要点

  • 抗抑郁安慰剂期望由复合学习信号更新,该信号整合神经反馈与逐试次心境。
  • 安慰剂期望、神经反馈操纵及复合学习信号调制视觉皮层与背侧注意网络。
  • 学习到的安慰剂期望编码于突显网络,且随抑郁严重程度正向缩放。

核心结论

  • 在分钟时间尺度上,抗抑郁安慰剂效应由期望与心境改善之间的正反馈环路维持。
  • 学习过程中,安慰剂及其感知效应的表征在初级和次级感觉皮层增强。
  • 潜在的学习性安慰剂期望编码于突显网络。

研究设计与样本

  • 急性患者内横断面研究,纳入18至55岁未服药的抑郁症患者,于2017年2月21日至2021年3月1日在匹兹堡大学招募。
  • 采用抗抑郁安慰剂功能磁共振任务,通过视觉提示的快速起效抗抑郁输注操纵安慰剂相关期望,并用假视觉神经反馈控制其强化,同时评估期望与体验的心境改善。
  • 使用多层模型和强化学习分析期望与心境的逐试次演变,并将模型预测信号与血氧水平依赖(BOLD)反应的时空动态关联。

主要发现

  • 在60例抑郁症患者(平均[标准误]年龄24.5[0.8]岁;51例女性[85%])中,贝叶斯强化学习模型比较显示,抗抑郁安慰剂逐试次期望由整合感觉证据(神经反馈)和逐试次心境的复合学习信号更新(贝叶斯总体风险<0.001;超越概率=97%)。
  • 安慰剂期望、神经反馈操纵和复合学习信号调制视觉皮层和背侧注意网络(无阈值聚类增强[TFCE]=1-P>.95)。
  • 当参与者预期抗抑郁输注时,学习到的安慰剂期望调制突显网络(SN,TFCE=1-P>.95),且与抑郁严重程度正向缩放。

临床怎么用

  • 结果提示抗抑郁安慰剂效应可在短时间内通过期望与心境改善的正反馈环路维持,临床中应关注期望与心境相互强化的动态过程。
  • 学习性安慰剂期望编码于突显网络并与抑郁严重程度相关,提示突显网络可能是安慰剂效应个体差异的神经标志。

局限性

  • 本研究为横断面设计,无法推断因果关系。
  • 样本量有限(60例),且年龄范围较窄(18至55岁),女性占85%,外推需谨慎。
  • 研究为急性实验范式,安慰剂效应观察时间尺度为分钟级,长期临床意义尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Despite high antidepressant placebo response rates, the mechanisms underlying the persistence of antidepressant placebo effects are still poorly understood. OBJECTIVE: To investigate the neurobehavioral mechanisms underlying the evolution of antidepressant placebo effects using a reinforcement learning (RL) framework. DESIGN, SETTING, AND PARTICIPANTS: In this acute within-patient cross-sectional study of antidepressant placebos, patients aged 18 to 55 years not receiving medication for major depressive disorder (MDD) were recruited at the University of Pittsburgh between February 21, 2017, to March 1, 2021. INTERVENTIONS: The antidepressant placebo functional magnetic resonance imaging task manipulates placebo-associated expectancies using visually cued fast-acting antidepressant infusions and controls their reinforcement with sham visual neurofeedback while assessing expected and experienced mood improvement. MAIN OUTCOMES AND MEASURES: The trial-by-trial evolution of expectancies and mood was examined using multilevel modeling and RL, relating model-predicted signals to spatiotemporal dynamics of blood oxygenation level-dependent (BOLD) response. RESULTS: A bayesian RL model comparison in 60 individuals (mean [SE] age, 24.5 [0.8] years; 51 females [85%]) with MDD revealed that antidepressant placebo trial-wise expectancies were updated by composite learning signals multiplexing sensory evidence (neurofeedback) and trial-wise mood (bayesian omnibus risk <0.001; exceedance probability = 97%). Placebo expectancy, neurofeedback manipulations, and composite learning signals modulated the visual cortex and dorsal attention network (threshold-free cluster enhancement [TFCE] = 1 - P >.95). As participants anticipated antidepressant infusions, learned placebo expectancies modulated the salience network (SN, TFCE = 1 - P >.95), positively scaling with depression severity. CONCLUSIONS AND RELEVANCE: Results of this cross-sectional study suggest that on a timescale of minutes, antidepressant placebo effects were maintained by positive feedback loops between expectancies and mood improvement. During learning, representations of placebos and their perceived effects were enhanced in primary and secondary sensory cortices. Latent learned placebo expectancies were encoded in the SN.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Peciña M, Chen J, Karp JF, et al. Dynamic Feedback Between Antidepressant Placebo Expectancies and Mood. JAMA Psychiatry. 2023. PMID: 36857039. doi:10.1001/jamapsychiatry.2023.0010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。